Streetbeat News

Analyst Ratings

F

TSLA

Morgan Stanley analyst Adam Jonas maintained an 'overweight' rating on Tesla with a price target of $200, stating that Tesla's ubiquity in the EV market is limited. He believes that legacy automakers like Ford will come up with compelling EV products, potentially impacting Tesla's market share.

Portfolio Pulse from Anan Ashraf

June 01, 2023 | 6:43 am

QQQ

SPY

Jim Cramer warns that the Federal Reserve's potential rate hikes could tip the economy into a recession. He suggests that the Fed should wait and assess the situation before making any decisions. U.S. markets ended in the red on Wednesday, with SPY and QQQ both closing lower.

Portfolio Pulse from Bhavik Nair

June 01, 2023 | 6:27 am

NVDA

STLA

VZ

Bill Miller IV, now 80% owner of Miller Value Partners, discussed the firm's transition and stock views on CNBC. He expressed skepticism about chasing big-cap tech stocks like Nvidia at a $1-trillion valuation and suggested looking for value in out-of-favor sectors. Miller IV mentioned Stellantis and Verizon as undervalued stocks.

Portfolio Pulse from Ryan Glosier

May 31, 2023 | 11:12 pm

HOTH

EF Hutton has assumed a 'Buy' rating and set a $14 price target on Hoth Therapeutics (HOTH).

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 9:32 pm

NICE

In the last 3 months, 4 analysts have provided 12-month price targets for NICE Ltd (NASDAQ:NICE), with an average target of $246.75, representing a 5.94% decrease from the previous average of $262.33. The company has received 3 bullish and 1 somewhat bullish ratings.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 9:02 pm

INTC

21 analysts have provided ratings for Intel (NASDAQ:INTC) within the last quarter, with an average price target of $28.98, implying a downside compared to the current price of $31.44. The average price target has increased by 5.38% over the past month.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 9:01 pm

HOTH

EF Hutton has reiterated its Buy rating and $14 price target on Hoth Therapeutics (HOTH).

Portfolio Pulse from Bill Haddad

May 31, 2023 | 9:01 pm

CIEN

In the last quarter, Ciena (NYSE:CIEN) received 5 bullish, 4 somewhat bullish, and 1 indifferent rating from 10 analysts. The average price target is $67.0, up 4.28% from the previous target of $64.25, implying an upside compared to the current price of $46.74.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 9:01 pm

SLAB

In the last 3 months, 4 analysts have offered 12-month price targets for Silicon Laboratories (NASDAQ:SLAB), with an average price target of $176.0, a 12.33% decrease from the previous average price target of $200.75.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 9:00 pm

BBLG

EF Hutton has initiated coverage on Bone Biologics (BBLG) with a Buy rating and a $2.25 price target.

Portfolio Pulse from Bill Haddad

May 31, 2023 | 8:52 pm